Trimeris, Roche submit Fuzeon MAA

TRMS and partner Roche (SWX:ROCZ) submitted an MAA for EU approval of TRMS's Fuzeon enfuvirtide (formerly T-20) to treat HIV infection. On Tuesday, the partners said they submitted an NDA to the FDA f...